|
|||||
|
|
A real‐world study of treatment patterns and outcomes in US managed‐care patients with type 2 Diabetes initiating injectable therapies |
|
| Authors: | Wenhui Wei PhD MS MBA Erin Buysman MS Michael Grabner PhD Lin Xie MA MS Lee Brekke PhD Xuehua Ke PhD James W. Chu MD FACE Philip A. Levin MD |
| Affiliation: | 1. Sanofi US, Inc., Bridgewater, New Jersey;2. Optum, Eden Prairie, Minnesota;3. HealthCore, Inc., Wilmington, Delaware;4. STATinMED Research, Ann Arbor, Michigan;5. Monterey Endocrine & Diabetes Institute, Monterey, California;6. MODEL Clinical Research, Baltimore, Maryland |
| Abstract: | |
| Keywords: | basal insulin database research incretin therapy observational study type 2 diabetes |